Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04800484
Other study ID # 201811701
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 7, 2019
Est. completion date December 1, 2025

Study information

Verified date December 2023
Source University of Iowa
Contact Jason M Wilken, PT, PhD
Phone 319-335-6857
Email jason-wilken@uiowa.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study evaluates the effect of ankle foot orthosis (AFO) heel height and stiffness on the forces and motion of the lower limb during over-ground walking in individuals who use an AFO for daily walking. Previous studies suggest that heel height and stiffness effect limb loading, but these data and the analysis techniques applied are limited. In this study, heel cushions with different height and stiffness's (4 conditions) will be placed in participants shoes and they will walk at controlled and self-selected speeds. Participants will also walk with their AFO as configured prior to enrollment, and with no AFO if possible. The proposed study will provide evidence that can be used by clinicians and researchers to align braces that most effectively improve function during every-day walking.


Description:

In this study the investigators to evaluate the effect of ankle foot orthosis (AFO) heel height and stiffness on the forces and motion of the lower limb during over-ground walking in individuals who use an AFO for daily walking. Previous studies suggest that heel height and stiffness effect limb loading, but these data and the analysis techniques applied are limited. Two groups of subjects with impairments below the knee, that result in functional deficits and require daily AFO use, will be recruited for this study. The first group will have unilateral deficits associated with musculoskeletal injury or disease (Group 1), and the second group will have bilateral or unilateral deficits associated with peripheral nervous system disease (Group 2). Lower limb forces and body motion will be assessed using computerized motion capture and force plates in the floor, as individuals walk over-ground. Small reflective markers placed on the participant's skin and force measuring plates in the floor will be used. Participants will walk with their clinically provided AFO, with added heel cushions of two different heights and stiffness's (4 conditions) at a controlled velocity and self-selected velocity. If able, they will walk without their AFO at a self-selected pace. Participants will be asked to provide information regarding their health condition and opinions of the conditions tested.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 1, 2025
Est. primary completion date December 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility GROUP 1 Patient Inclusion criteria - Ages: 18-70 - Daily AFO use to address unilateral, below knee functional deficits that result from limb injury or musculoskeletal disease (e.g. fracture, muscle and/or nerve injury, ankle arthritis) - Greater than 2 weeks using their current AFO - Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.) - Ability to walk at a slow to moderate pace - AFO fits into traditional footwear - Able to read and write in English and provide written informed consent GROUP 1 Patient Exclusion criteria - Pain > 6/10 while walking during testing or an increase in pain during testing of > 2/10. - Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord Injury, or other conditions that result in lower limb spasticity). - Disorder or disease that affects peripheral nerve function (e.g. diabetes, Charcot Marie Tooth). - Limited contralateral lower limb function due to injury or neurological/musculoskeletal disorder. - Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop, free motion), Charcot Restraint Orthotic Walker (CROW) boot, AFOs that restrict all motion in the ankle and foot. - Use of an AFO that crosses the knee (Knee brace) - Insufficient space in shoe to accommodate the tallest heel wedge and their AFO - Visual or hearing impairments that limit walking ability or could limit the ability to comply with instructions given during testing - Pregnancy - Per participant self-report. Due the expected small number of pregnant individuals, and resulting inability to account for its effect on resulting outcomes participants will be withdrawn from the study. - Body Mass index > 40. GROUP 2 Patient Inclusion Criteria - Ages: 18-70 - Daily AFO use to address below knee functional deficits that result from disease involving the peripheral nervous system (e.g. Charcot Marie Tooth, Multiple Sclerosis, diabetes) - Greater than 2 weeks using their current AFO (unilateral or bilateral) - Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.) - AFO fits into traditional footwear - Ability to walk at a slow to moderate pace - Able to read and write in English and provide written informed consent GROUP 2 Patient Exclusion Criteria - Pain > 6/10 while walking or an increase in pain during testing of > 2/10 - Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord Injury, or other conditions that result in lower limb spasticity) - Limited function due to limb injury (e.g. fracture, muscle and/or nerve injury) - Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop, free motion), Charcot Restraint Orthotic Walker (CROW) boot, AFOs that restrict all motion in the ankle and foot. - Use of an AFO that crosses the knee (Knee brace) - Insufficient space in shoe to accommodate the tallest heel wedge and their AFO - Visual or hearing impairment that limit walking ability or limit the ability to comply with instructions given during testing - Pregnancy - Per participant self-report. Due the expected small number of pregnant individuals, and resulting inability to account for its effect on resulting outcomes participants will be withdrawn from the study - Body Mass index > 40.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Tall Soft
Tall heel wedge made of soft foam
Tall Firm
Tall heel wedge made of firm foam
Short Soft
Short heel wedge made of soft foam
Short Firm
Short heel wedge made of firm foam

Locations

Country Name City State
United States University of Iowa Iowa City Iowa

Sponsors (1)

Lead Sponsor Collaborator
University of Iowa

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Activities-Specific Balance Confidence (ABC) The ABC provides a standardized evaluation of balance confidence across a range of common daily tasks. Baseline
Other PROMIS Patient reported outcomes for physical function The Patient Reported Outcome Information System (PROMIS) physical function Computer Adaptive Test (CAT) is a computerized assessment measuring physical function. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents more of the measured variable than the population average. Baseline
Primary Center of pressure velocity timing Timing of peak center of pressure velocity (percent stance) during gait. Baseline
Primary Center of pressure velocity magnitude Magnitude of peak center of pressure velocity (m/s) during gait. Baseline
Primary Modified Socket Comfort Score (Comfort) Comfort scores range from 0 = most uncomfortable to 10 = most comfortable. Baseline
Primary Modified Socket Comfort Score (Smoothness) Smoothness scores range from 0 = least smooth to 10 = most smooth. Baseline
Primary Numerical Pain Rating Scale Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable. Baseline
Primary Participant wedge preference The participant will rank order their preference for their Clinical AFO, Tall Soft, Tall Firm, Short Soft, or Short Firm wedge on a questionnaire. Baseline
Secondary Ankle Range of Motion Ankle range of motion (degrees) during gait. Baseline
Secondary Peak Ankle Moment Peak ankle moment (Nm/kg) during gait. Baseline
Secondary Peak Ankle Power Peak ankle power (W/kg) during gait. Baseline
See also
  Status Clinical Trial Phase
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Recruiting NCT05546541 - Epidemiology and Nutrition
Completed NCT05071469 - Comparison of Two Different Treatment Methods N/A
Completed NCT05041400 - Distribution of Knee Isokinetic Angle-specific Moments and Ratios N/A
Not yet recruiting NCT06216028 - Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis Phase 3
Not yet recruiting NCT04932993 - Writing Down Goals N/A
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Completed NCT02269254 - Persona Versus NexGen N/A
Completed NCT02257489 - Phase 1 Study of ACE-083 in Healthy Subjects Phase 1
Completed NCT02256098 - RSA RCT: ATTUNEā„¢ TKA Versus PFC Sigma TKA N/A
Completed NCT01979731 - Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders N/A
Active, not recruiting NCT01440153 - Additional Exercise Program in Professional Dancers N/A
Completed NCT00968266 - Improving Beliefs About Medication in Patients With Rheumatoid Arthritis N/A
Completed NCT05222126 - Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome N/A
Completed NCT05062694 - Physical Therapy Management Of The Patient With Central Sensitization
Recruiting NCT05564182 - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain N/A
Completed NCT04009369 - Impacts of Physiotherapy Services in a Quebec Emergency Department N/A
Completed NCT05561452 - The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome N/A
Recruiting NCT05432609 - Standardization and Reproducibility Regarding Scanning Procedures and Measurements of Weight-bearing Cone Beam CT in the Lower Extremity
Completed NCT04959162 - The Effect of Theoretical Knowledge on Resident's Practical Performance in Musculoskeletal Ultrasound N/A